HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by LaFrance, N. D. Articles by Duelfer, T. Search for Related Content PubMed PubMed Citation Articles by LaFrance, N. D. Articles by Duelfer, T.

Decreased Accumulation of Isopropyl-Iodoamphetamine (I-123) in Brain Tumors

The Johns Hopkins Medical Institutions, Baltimore, Maryland

Correspondence: For reprints contact: Norman D. LaFrance, MD, Nuclear Medicine, John Hopkins Medical Institutions, 615 N. Wolfe Street, Baltimore, MD 21205.

ABSTRACT

Four out of four patients with brain tumors were observed to have impaired N-isopropyl-p-[¹²³I]iodoamphetamine (IAMPH) accumulation by the lesions even though brain scans with technetium-99m diethylenetriamine pentaacetic acid were normal in two. IAMPH may be a more sensitive means of detecting regional cerebral disease than tracers primarily sensitive to blood-flow abnormalities or impairment of the blood-brain barrier.

This article has been cited by other articles:

				Y. Akiyama, K. Moritake, T. Yamasaki, Y. Kimura, A. Kaneko, Y. Yamamoto, T. Miyazaki, and M. Daisu The Diagnostic Value of 123I-IMP SPECT in Non-Hodgkin's Lymphoma of the Central Nervous System J. Nucl. Med., November 1, 2000; 41(11): 1777 - 1783. [Abstract] [Full Text] [PDF]